Elevated levels of miR-499 protect ischemic myocardium against uric acid in patients undergoing off-pump CABG

Cor et Vasa

Volumn 58, Issue 6, 2016, Pages e600-e608

  Pourrajab, Fatemeh ^a   Sharifi, Marzieh ^a   Hekmatimoghaddam, Seyedhossein ^a   Khanaghaei, Masoud ^a   Rahaie, Mahdi ^b  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Ischemia; Mechanism; MiR 499; Uric acid

Indexed keywords

BIOCHEMICAL MARKER; MICRORNA; MICRORNA 499; TROPONIN I; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENZYME BLOOD LEVEL; FAST MUSCLE; GENE EXPRESSION; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE OVERLOAD; HUMAN; MAJOR CLINICAL STUDY; OFF PUMP CORONARY SURGERY; OXIDATIVE STRESS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84957916484     PISSN: 00108650     EISSN: 18037712     Source Type: Journal    
DOI: 10.1016/j.crvasa.2016.01.002     Document Type: Article

References (31)

1. [1] Qin, H., Chen, G., Liang, M., et al. The altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of miR-499 on myocardial ischemic reperfusion injury. Journal of Translational Medicine 11:154 (2013), 1–9.
2. [2] Adachi, T., Nakanishi, M., Otsuka, Y., et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clinical Chemistry 56 (2010), 1183–1185.
3. [3] Olivieri, F., Antonicelli, R., Spazzafumo, L., et al. Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction. International Journal of Cardiology 172 (2014), e276–e278.
4. [4] Corsten, M.F., Dennert, R., Jochems, S., et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circulation: Cardiovascular Genetics 3 (2010), 499–506.
5. [5] Fukushima, Y., Nakanishi, M., Nonogi, H., et al. Assessment of plasma miRNAs in congestive heart failure. Circulation Journal 75 (2011), 336–340.
6. [6] Brodov, Y., Behar, S., Goldenberg, I., et al. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] Study). American Journal of Cardiology 104 (2009), 194–198.
7. [7] Dunkelgrun, M., Welten, G.M., Goei, D., et al. Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery. American Journal of Cardiology 102 (2008), 797–801.
8. [8] Lapsia, V., Johnson, R.J., Dass, B., et al. Elevated uric acid increases the risk for acute kidney injury. American Journal of Medicine 125 (2012), 302.e9–302.e17.
9. [9] Hillis, G.S., Cuthbertson, B.H., Gibson, P.H., et al. Uric acid levels and outcome from coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery 138 (2009), 200–205.
10. [10] Şahin, D.Y., Gur, M., Elbasan, Z., et al. Predictors of preinterventional patency of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of neutrophil to lymphocyte ratio and uric acid level. Experimental and Clinical Cardiology 18 (2013), e77–e81.
11. [11] Gerritsena, W.B.M., Boven, W.J.P., Driessen, A.H.G., et al. Off-pump versus on-pump coronary artery bypass grafting: oxidative stress and renal function. European Journal of Cardio-Thoracic Surgery 20 (2001), 923–929.
12. [12] Gonenc, A., Hacsevki, A., Griffiths, H.R., et al. Free radical reaction products and antioxidant capacity in beating heart coronary artery surgery compared to conventional bypass. Biochemistry 76 (2011), 677–685.
13. [13] Gerritsen, W.B., Boven, W.P., Boss, D.S., et al. Malondialdehyde in plasma, a biomarker of global oxidative stress during mini-CABG compared to on- and off-pump CABG surgery: a pilot study. Interactive Cardiovascular and Thoracic Surgery 5 (2006), 27–31.
14. [14] Peivandi, A.A., Dahm, M., Opfermann, U.T., et al. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction. Herz 29 (2004), 658–664.
15. [15] Chang, P.P., Sussman, M.S., Conte, J.V., et al. Postoperative ventricular function and cardiac enzymes after on-pump versus off-pump CABG surgery. American Journal of Cardiology 89 (2002), 1107–1110.
16. [16] van Boven, P.W., Gerritsen, B.W., Driessen, H.A., et al. Myocardial oxidative stress, and cell injury comparing three different techniques for coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery 34 (2008), 969–975.
17. [17] Olivieri, F., Antonicelli, R., Lorenzi, M., et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. International Journal of Cardiology 167 (2013), 531–536.
18. [18] Caputo, M., Saif, J., Rajakaruna, C., et al. MicroRNAs in vascular tissue engineering and 3 post-ischemic neovascularization. Advanced Drug Delivery Reviews, 2015, 10.1016/j.addr.2015.05.003.
19. [19] Shankar, A., Klein, B.E.K., Nieto, F.J., Klein, R., Association between serum uric acid level and peripheral arterial disease. Atherosclerosis 196 (2008), 749–755.
20. [20] Tavil, Y., Gungor-Kaya, M., Ozhan-Oktar, S., et al. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 197 (2008), 159–163.
21. [21] Oberbach, A., Neuhaus, J., Jehmlich, N., et al. A global proteome approach in uric acid stimulated human aortic endothelial cells revealed regulation of multiple major cellular pathways. International Journal of Cardiology 176 (2014), 746–752.
22. [22] Chaturvedi, P., Kalani, A., Givvimani, S., et al. Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo: an epigenetic mechanism. Physiological Genomics 46 (2014), 245–255.
23. [23] Ando, H., Asai, T., Koide, H., et al. Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499. Journal of Controlled Release 181 (2014), 32–39.
24. [24] Sesti, G., Hribal, M.L., Procopio, T., et al. Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. Nutrition, Metabolism and Cardiovascular Diseases 24 (2014), 1365–1372.
25. [25] Park, J.H., Jin, Y.M., Hwang, S., et al. Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide 32 (2013), 36–42.
26. 2+ exchanger-mediated mitochondrial calcium overload. Cell Calcium 51 (2012), 402–410.
27. [27] Zhang, L., Liu, J., Liu, F., et al. miR-499 induces cardiac differentiation of rat mesenchymal stem cells through Wnt/β-catenin signaling pathway. Biochemical and Biophysical Research Communications 420 (2012), 875–881.
28. [28] Ling, T., Wang, X., Chai, Q., et al. Regulation of the SK3 channel by microRNA-499. Potential role in atrial fibrillation. Heart Rhythm 10 (2013), 1001–1009.
29. [29] Lo, B., Fijnheer, R., Nierich, A.P., et al. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Annals of Thoracic Surgery 79 (2005), 1530–1535.
30. [30] Ishida, K., Kimura, F., Imamaki, M., et al. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery 29 (2006), 501–505.
31. [31] Perticone, F., Maio, R., Tassone, J.E., et al. Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients. International Journal of Cardiology 167 (2013), 232–236.